The association between short-acting β2-agonist over-prescription, and patient-reported acquisition and use on asthma control and exacerbations: data from Australia
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Beekman, M. J., Bosnic-Anticevich, S., Botini, F., Carter, V., Catanzariti, A., Doan, J., Fletton, K., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Stewart, D., Willet, B., OPCA Improving Asthma outcomes in Australia Research Group, Bateman, E.
The future of allergic rhinitis management: a partnership between health care professionals and patients
Cvetkovski, B., Muscat, D. M., Bousquet, J., Cabrera, M., House, R., Katsoulotos, G., Lourenço, O. M., Papadopoulos, N., Price, D., Rimmer, J., Ryan, D., Smith, P., Yan, K. Y., Bosnic-Anticevich, S.
World Allergy Organization Journal, vol. 17, no. 3, 100873
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
Chen, W., Tran, T. N., Sadatsafavi, M., Murray, R. B., Boon Wong, N. C., Ali, N., Ariti, C., Bulathsinhala, L., Garcia Gil, E., FitzGerald, J. M., Alacqua, M., Al-Ahmad, M., Altraja, A., Al-Lehebi, R., Bhutani, M., Bjermer, L., Bjerrum, A., Bourdin, A., von Bülow, A., Busby, J., Canonica, G. W., Carter, V., Christoff, G. C., Cosio, B. G., Costello, R. W., Fonseca, J. A., Gibson, P. G., Yoo, K. H., Heaney, L. G., Heffler, E., Hew, M., Hilberg, O., Hoyte, F., Iwanaga, T., Jackson, D. J., Jones, R. C., Koh, M. S., Kuna, P., Larenas-Linnemann, D., Lehmann, S., Lehtimäki, L., Lyu, J., Mahboub, B., Maspero, J., Menzies-Gow, A. N., Newell, A., Sirena, C., Papadopoulos, N. G., Papaioannou, A. I., Perez-de-Llano, L., Perng (Steve), D., Peters, M. J., Pfeffer, P. E., Porsbjerg, C. M., Popov, T. A., Rhee, C. K., Salvi, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Ra, S. W., Wang, E., Wechsler, M. E., Price, D. B.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 12, no. 2, pp. 536-539
Association between T2-related co-morbidities and effectiveness of biologics in severe asthma
Wechsler, M. E., Scelo, G., Larenas-Linnemann, D. E., Torres-Duque, C. A., Maspero, J. F., Tran, T. N., Murray, R. B., Martin, N., Menzies-Gow, A., Hew, M., Peters, M. J., Gibson, P. G., Christoff, G. C., Popov, T. A., Côté, A., Bergeron, C., Dorscheid, D., FitzGerald, J. M., Chapman, K. R., Boulet, L. P., Bhutani, M., Jiménez-Maldonado, L., Duran-Silva, M., Rodriguez, B., Celis-Preciado, C. A., Cano-Rosales, D. J., Solarte, I., Fernandez-Sanchez, M. J., Parada-Tovar, P., von Bülow, A., Bjerrum, A. S., Suppli Ulrik, C., Assing, K. D., Rasmussen, L. M., Hansen, S., Altraja, A., Bourdin, A., Taillé, C., Charriot, J., Roche, N., Papaioannou, A. I., Kostikas, K., Papadopoulos, N. G., Salvi, S., Long, D., Mitchell, P., Costello, R. W., Sirena, C., Cardini, C., Heffler, E., Puggioni, F., Canonica, G. W., Guida, G., Iwanaga, T., Al-Ahmad, M., García, U., Kuna, P., Fonseca, J. A., Al-Lehebi, R., Koh, M. S., Rhee, C. K., Cosio, B. G., Perez de Llano, L., Perng, D. W., Wan-Chun Huang, E., Wang, H., Tsai, M., Mahboub, B., Salameh, L. I. J., Jackson, D. J., Busby, J., Heaney, L. G., Pfeffer, P. E., Goddard, A. G., Wang, E., Hoyte, F. C., Chapman, N. M., Katial, R., Carter, V., Bulathsinhala, L., Eleangovan, N., Ariti, C., Lyu, J., Porsbjerg, C., Price, D., Sadatsafavi, M.
American Journal of Respiratory and Critical Care Medicine, vol. 209, no. 3, pp. 262-272
Development of theoretically informed audit and feedback: an exemplar from a complex implementation strategy to improve asthma self-management in UK primary care
McClatchey, K., Sheldon, A., Steed, L., Sheringham, J., Holmes, S., Preston, M., Appiagyei, F., Price, D., Taylor, S. J., Pinnock, H., IMP2ART Programme Group.
Journal of Evaluation in Clinical Practice, vol. 30, no. 1, pp. 86-100
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma
Scadding, G. K., McDonald, M., Backer, V., Scadding, G., Bernal-Sprekelsen, M., Conti, D. M., De Corso, E., Diamant, Z., Gray, C., Hopkins, C., Jesenak, M., Johansen, P., Kappen, J., Mullol, J., Price, D., Quirce, S., Reitsma, S., Salmi, S., Senior, B., Thyssen, J. P., Wahn, U., Hellings, P. W.
Risk of pneumonia in patients with COPD initiating fixed dose inhaled corticosteroid (ICS) / long-acting bronchodilator (LABD) formulations containing extrafine beclometasone dipropionate versus patients initiating LABD without ICS
Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., Roche, N., Şen, E., Singh, D., Vogelmeier, C. F., Nudo, E., Carter, V., Skinner, D., Vella, R., Soriano, J. B., Kots, M., Georges, G.
Pragmatic and Observational Research, vol. 15, pp. 1-16
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
Scelo, G., Torres-Duque, C. A., Maspero, J. F., Tran, T. N., Murray, R. B., Martin, N., Menzies-Gow, A., Hew, M., Peters, M. J., Gibson, P. G., Christoff, G. C., Popov, T. A., Côté, A., Bergeron, C., Dorscheid, D., FitzGerald, J. M., Chapman, K. R., Boulet, L. P., Bhutani, M., Sadatsafavi, M., Jiménez-Maldonado, L., Duran-Silva, M., Rodriguez, B., Celis-Preciado, C. A., Cano-Rosales, D. J., Solarte, I., Fernandez-Sanchez, M. J., Parada-Tovar, P., von Bülow, A., Bjerrum, A. S., Suppli Ulrik, C., Assing, K. D., Assing, K. D., Hansen, S., Altraja, A., Bourdin, A., Taillé, C., Charriot, J., Roche, N., Papaioannou, A. I., Kostikas, K., Papadopoulos, N. G., Salvi, S., Long, D., Mitchell, P., Costello, R. W., Sirena, C., Cardini, C., Heffler, E., Puggioni, F., Canonica, G. W., Guida, G., Iwanaga, T., Al-Ahmad, M., Larenas-Linnemann, D., García, U., Kuna, P., Fonseca, J. A., Al-Lehebi, R., Koh, M. S., Rhee, C. K., Cosio, B. G., Perez de Llano, L., Perng Steve, D., Wan-Chun Huang, E., Wang, H., Tsai, M., Mahboub, B., Salameh, L. I. J., Jackson, D., Busby, J., Heaney, L. G., Pfeffer, P. E., Goddard, A. G., Wang, E., Hoyte, F., Wechsler, M. E., Chapman, N., Katial, R., Carter, V., Bulathsinhala, L., Eleangovan, N., Ariti, C., Lyu, J., Price, D., Porsbjerg, C.
Annals of Allergy, Asthma, and Immunology, vol. 132, no. 1, pp. 42-53
Impact of biologic initiation on oral corticosteroids in the International Severe Asthma Registry and the Optimum Patient Care Research Database: a pooled analysis
Cochrane,, B., Altraja, A., Bøgvald Aarli, B., Al-Ahmad, M., Bergeron, C., Bjermer, L., Bourdin, A., Price, D., Bulkhi, A. A., Christoff, G. C., Costello, R. W., Zsuzsanna, C., Dorscheid, D. R., Silva Ferreira, J. A., Jiménez-Maldonado, L., Juang, Y. R., Chen, W., Tran, T. N., Emmanuel, B., Brusselle, G., Heaney, L. G., Heffler, E., Jackson, D. J., Katial, R., Kostikas, K., Kuna, P., Larenas-Linnemann, D., Lehtimäki, L., Liu, A., Ludviksdottir, D., Mahboub, B., Menzies-Gow, A., Perez-De-Llano, L., Peters, M. J., Pfeffer, P. E., Márcio Pitrez, P., Popov, T. A., Rhee, C. K., Saldarini, F., Schleich, F., Sheu, C., Stjepanovic, N., Tohda, Y., Suppli Ulrik, C., Wang, E., Wechsler, M. E., Beastall, A., Bulathsinhala, L., Murray, R. B., Scelo, G.
European Respiratory Society (ERS) Congress 2024, PA2175
Phenotype and biomarkers in patients who initiated biologics therapy stratified by oral corticosteroid use in the International Severe Asthma Registry
Torres-Duque, C. A., Shi Kai Chan, J., Fletton, K., Townend, J., Dorscheid, D. R., Altraja, A., Suppli Ulrik, C., Beastall, A., Goh, C. Y., Navaratnam, V., Bulathsinhala, L., Carter, V., Wang, Z., Gall, R., Cheng, W., Bøgvald Aarli, B., Bergeron, C., Bourdin, A., Bulkhi, A. A., Christoff, G. C., Fonseca, J. A., Jenkins, C., Koh, M. S., Kostikas, K., Loukides, S., Jiménez-Maldonado, L., Kuna, P., Louis, R., Mahboub, B., Murray, R. B., Márcio Pitrez, P., Puggioni, F., Al-Ahmad, M., Bjermer, L., Björnsdóttir, U. S., Cosio, B. G., Costello, R. W., Zsuzsanna, C., Iwanaga, T., Larenas-Linnemann, D., Lehtimäki, L., Sivori, M., Rhee, C. K., Salvi, S., Taube, C., Price, D.
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
Papi, A., Hughes, R., del Olmo, R., Agusti, A., Chipps, B. E., Make, B., Tomaszewski, E., Peres Da Costa, K., Srivastava, D., Vestbo, J., Janson, C., Burgel, P. R., Price, D., The NOVELTY Scientific Community and the NOVELTY study investigators
Therapeutic advances in respiratory disease, vol. 18
Does mixing inhaler devices lead to unchecked inhaler technique errors in patients with COPD?: Findings from the cross-sectional observational MISMATCH study
Dijk, L., Kerkhof, M., Driessen, M., Gerritsma, Y. H., Bosnic-Anticevich, S., Correia-De-Sousa, J., Dekhuijzen, P. N., Leving, M., Price, D. B., Tsiligianni, I., Usmani, O., Kerstjens, H. A., Kocks, J. W.
BMJ Open Respiratory Research, vol. 10, no. 1, e001821
Identifying opportunities for earlier diagnosis of high-risk COPD patients in Australia: an observational study
Dickens, A. P., Jenkins, C., Evans, A., Hancock, K., Sharma, A., Cochrane,, B., Leong, P., Ko, B., Heraud, F., Le Cheng, P., Roussos, A., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Ghisla, C., Le, T., Le Lievre, C. E., Murray, R., Ranasinghe, K., Stewart, D., van Melle, M., Vella, R., Wiseman, R., Price, D.
TSANZSRS 2024
Contributions to Conferences: Abstracts
Handling Class Imbalance in Machine Learning-based Prediction Models: A Case Study in Asthma Management
Budiarto, A., Wilson, A., Price, D., Shah, S. A., Sheikh, A.
Chapters in Books, Reports and Conference Proceedings: Conference Proceedings
Biomarkers expression, treatment and disease burden in a cohort of Italian patients affected by severe asthma: a sub analysis of the ISAR EVEREST study
Heffler, E., Canonica, G. W., Blasi, F., Paggiaro, P., Brussino, L., Caminati, M., Bagnasco, D., Camiciottoli, G., Bonini, M., Pelaia, G., Detoraki, A., Crimi, C., Boarino, S., Cristofari, G., Erhard, C., Carter, V., Price, D., Cook, B., Tram, T. N., Le, T. T., SANI and ISAR EVEREST study groups
Burden of illness in a cohort of Italian patients eligible for biologics for asthma but not treated: a sub analysis of the real-world ISAR EVEREST study
Bonini, M., Canonica, G. W., Blasi, F., Paggiaro, P., Heffler, E., Brussino, L., Caminati, M., Bagnasco, D., Camiciottoli, G., Pelaia, G., Detoraki, A., Crimi, C., Boarino, S., Cristofari, G., Erhard, C., Carter, V., Price, D., Cook, B., Tran, T. N., Le, T. T., SANI and ISAR EVEREST study groups
Potential value of quality improvement in difficult-to-treat and severe asthma in Australia; an opportunity analysis
Price, D., Heraud, F., Le Lievre, C. E., Bushell, N., De Silva, N., Le Cheng, P., Roussos, A., Macfie, D., Hu, N. H., Botini,, F., Carter, V., Blakey, J., Claxton, S., Da Silva, E., Goudge, R., Horadagoda, C., Iyer, J., Katsoulotos, G., Kelly, W., Laska, I., Marchand, B., Navaratnam, V., Nolan-Neylan, S., Pin Lim, K., Smith, P., Smith, T., Thien, F., Zubrinich, C., The OPC High Risk Asthma Study Group
Clinical remission following biologic initiation in severe asthma: results of the International Severe Asthma Registry (ISAR)
Scelo, G., Tran, T. N., Le, T. T., Faregas, M., Martin, N., Menzies-Gow, A., Eileen, W., Wechsler, M. E., Canonica, G. W., Heffler, E., Heaney, L. G., Jackson, D., Pfeffer, P., Busby, J., Porsbjerg, C. M., Hew, M., Peters, M., Gibson, P. G., Al-Ahmad, M., Bergeron, C., Sadatsafavi, M., Llano, L. P. d., Cosio, B. G., Kuna, P., Perng, D., Iwanaga, T., Torres-Duque, C. A., Linnemann, D. L., Mahboub, B., Al-Lehebi, R., Fonseca, J. A., Rhee, C. K., Maspero, J., Siyue, M. K., Christoff, G. C., Popov, T. A., Kwiatek, J., Carter, V., Goh, C., Bulathsinhala, L., Beastall, A., Price, D.
Identifying opportunities for earlier diagnosis of high-risk COPD patients in Australia: an observational study
Dickens, A. P., Jenkins, C., Evans, A., Hancock, K., Sharma, A., Cochrane,, B., Leong, P., Ko, B., Heraud, F., Le Cheng, P., Roussos, A., Bosnic-Anticevich, S., Botini, F., Carter, V., Catanzariti, A., Ghisla, C., Le, T., Le Lievre, C. E., Murray, R., Ranasinghe, K., Stewart, D., van Melle, M., Vella, R., Wiseman, R., Price, D.
Medication success among real-world users of budesonide/glycopyrrolate/formoterol fumarate (BGF) for the management of COPD in a UK primary care population
Müllerová, H., Chan, J. S. K., Heatley, H., Carter, V., Townend, J., Skinner, D., Franzen, S., Castaneda, J., Marshall, J., Price, D.
Adult severe asthma registries: a global and growing inventory
Cushen, B., Koh, M. S., Tran, T. N., Martin, N., Murray, R. B., Uthaman, T., Goh, Y. Y. C., Vella, R., Eleangovan, N., Bulathsinhala, L., Maspero, J. F., Peters, M. J., Schleich, F., Pitrez, P. M., Christoff, G., Sadsatsafavi, M., Torres-Duque, C. A., Porsbjerg, C., Altraja, A., Lehtimäki, L., Bourdin, A., Taube, C., Papadopoulos, N. G., Zsuzsanna, C., Björnsdóttir, U. S., Salvi, S., Heffler, E., Iwanaga, T., Al-Ahmad, M., Larenas-Linnemann, D., van Boven, J. F., Bøgvald Aarli, B., Kuna, P., Loureiro, C. C., Al-Lehebi, R., Lee, J. H., Marina, N., Bjermer, L., Sheu, C., Sheu, C., Busby, J., Wang, E., Price, D.
Pragmatic and Observational Research, vol. 2023, no. 14, pp. 127—147
COPD exacerbations during and beyond the COVID-19 pandemic in the UK
Carter, V., Skinner, D., Shi Kai Chan, J., Patel, M., Hubbard, R. R., Parikh, H., Price, D.
ERS 2023 International Congress
Contributions to Conferences: Abstracts
Association of blood eosinophils and exhaled nitric oxide with exacerbations and lung function in patients with asthma, COPD, and asthma + COPD: the NOVELTY study
Muiser, S., Müllerová, H., Belton, L., Erhard, C., Rusibamayila, N., Agusti, A., Faner, R., Pavord, I. D., Inoue, H., Price, D., Olaguibel, J., Kerstjens, H. A. M., van den Berge, M.
Real-world associations between outcomes and biomarkers in severe asthma patients treated with biologics
Townend, J., N TRAN, T., Martin, N., Menzies-Gow, A. N., Wang, E., Wechsler, M. E., Walter Canonica, G., Heffler, E., Llano, L. P. d., Cosio, B. G., Hew, M., Peters, M., Gibson, P. G., Bosnic-Anticevitch, S., Heaney, L. G., Jackson, D. J., Pfeffer, P. E., Busby, J., Salvi, S., Christoff, G. C., Popov, T. A., Porsbjerg, C. M., Torres-Duque, C. A., Al-Lehebi, R., Al-Ahmad, M., Perng, D. W., Bergeron, C., Sadatsafavi, M., Mahboub, B., Iwanaga, T., Maspero, J. F., Kuna, P., Rhee, C. K., Larenas-Linnemann, D., Papadopoulos, N. G., Papaioannou, A. L., Fonseca, J. A., Koh, M. S., Costello, R. W., Price, D.
European Respiratory Journal, vol. 62, no. Suppl. 67, PA1897
Real world biologic treatment response in severe asthma:: an analysis of the International Severe Asthma Registry (ISAR)
Le, T. T., Scelo, G., Tran, T. N., Faregas, M., Martin, N., Menzies-Gow, A. N., Eileen, W., Wechsler, M. E., Walter Canonica, G., Heffler, E., Heaney, L. G., Jackson, D., Pfeffer, P., Busby, J., Porsbjerg, C. M., Hew, M., Peters, M., Gibson, P. G., Al-Ahmad, M., Bergeron, C., Sadatsafavi, M., Llano, L. P. d., Cosio, B. G., Kuna, P., Perng, D., Iwanaga, T., Torres-Duque, C. A., Linnemann, D. L., Mahboub, B., Papadopoulos, N. G., Al-Lehebi, R., Fonseca, J. A., Rhee, C. K., Maspero, J., Siyue, M. K., Christoff, G. C., Popov, T. A., Kwiatek, J., Carter, V., Goh, C., Bulathsinhala, L., Beastall, A., Price, D.
Identifying opportunities for optimising the management of high-risk COPD patients in Australia: an observational study
Evans, A., Hancock, K., Dickens, A. P., Jenkins, C., Sharma, A., Cochrane, B., Leong, P. K. F., Ko, B., Heraud, F., Le Cheng, P., Roussos, A., Bosnic-Anticevich, S., Botini, F., Carter, V., Catanzariti, A., Ghisla, C., Le, T., Le Lievre, C. E., Murray, R. B., Ranasinghe, K., Stewart, D., van Melle, M., Vella, R., Wiseman, R., Price, D.
Cluster analyses from the real-world NOVELTY study: six clusters across the asthma COPD spectrum
Hughes, R., Rapsomaniki, E., Bansal, A. T., Vestbo, J., Price, D., Agusti, A., Beasley, R., Alacqua, M., Papi, A., Müllerová, H., Reddel, H. K., NOVELTY Scientific Community
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 9, pp. 2803-2811
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
Chen, W., Tran, T. N., Sadatsafavi, M., Murray, R., Wong, N. C. B., Ali, N., Ariti, C., Bulathsinhala, L., Gil, E. G., FitzGerald, J. M., Alacqua, M., Al-Ahmad, M., Altraja, A., Al-Lehebi, R., Bhutani, M., Bjermer, L., Bjerrum, A., Bourdin, A., von Bülow, A., Busby, J., Canonica, G. W., Carter, V., Christoff, G. C., Cosio, B. G., Costello, R. W., Fonseca, J. A., Gibson, P. G., Yoo, K., Heaney, L. G., Heffler, E., Hew, M., Hilberg, O., Hoyte, F., Iwanaga, T., Jackson, D. J., Jones, R. C., Koh, M. S., Kuna, P., Larenas-Linnemann, D., Lehmann, S., Lehtimäki, L., Lyu, J., Mahboub, B., Maspero, J., Menzies-Gow, A. N., Newell, A., Sirena, C., Papadopoulos, N. G., Papaioannou, A. I., Perez-de-Llano, L., Perng Steve, D., Peters, M., Pfeffer, P. E., Porsbjerg, C. M., Popov, T. A., Rhee, C. K., Salvi, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Ra, S., Wang, E., Wechsler, M. E., Price, D. B.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 9, pp. 2732-2747
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
Domingo, C., Rabe, K. F., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Rowe, P. J., Deniz, Y., Jacob-Nara, J. A., Radwan, A.
Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study
Kocks, J., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Voorham, J., Leving, M. T.
Technophobia is not the most significant patient-reported barrier to accepting a digital adherence package: an analysis of the MAGNIFY trial.
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K. M., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Igwe, F., Davis, S., Price, D.
British Thoracic Society
Contributions to Conferences: Abstracts
Updating estimates of Plasmodium knowlesi malaria risk in response to changing land use patterns across Southeast Asia.
Tobin, R. J., Harrison, L. E., Tully, M. K., Lubis, I. N. D., Noviyanti, R., Anstey, N. M., Rajahram, G. S., Grigg, M. J., Flegg, J. A., Price, D. J., Shearer, F. M.
Patterns of Care in the Management of High-Risk COPD in the US (2011-2019): An Observational Study for the CONQUEST Quality Improvement Program
Kerr, M., Tarabichi, Y., Evans, A., Mape, D., Pace, W. D., Carter, V., Couper, A., Drummond, M. B., Feigler, N., Federman, A., Gandhi, H., Hanania, N. A., Kaplan, A., Kostikas, K., Kruszyk, M., van Melle, M., Müllerová, H., Murray, R. B., Ohar, J. A., Pollack, M., Pullen, R., Williams, D. M., Wisnivesky, J., Han, M. K., Meldrum, C., Price, D.
The Lancet Regional Health - Americas, vol. 24, 100546
Asthma Exacerbations are Associated with a decline in Lung Function: A Longitudinal Population-Based Study
Soremekun, S., Heaney, L. G., Skinner, D., Bulathsinhala, L., Carter, V., Chaudhry, I., Hosseini, N., Eleangovan, N., Murray, R. B., Tran, T. N., Emmanuel, B., Garcia Gil, E., Menzies-Gow, A., Peters, M., Lugogo, N., Jones, R., Price, D.
